Page 99 - 南京医科大学学报自然科学版
P. 99

第41卷第12期            薛冰艳,顾丹阳,张心瑞,等. 双气囊小肠镜在小肠疾病临床诊治中的应用分析[J].
                 2021年12月                    南京医科大学学报(自然科学版),2021,41(12):1801-1805                      ·1805 ·


               [13] GASPAR J P,STELOW E B,WANG A Y. Approach to        ble⁃balloon endoscopic retrograde cholangiopancreatogra⁃
                    the endoscopic resection of duodenal lesions[J]. World J  phy for patients who underwent liver operation:A retro⁃
                    Gastroenterol,2016,22(2):600-617                   spective study[J]. World J Gastroenterol,2020,26(10):
               [14] RODRIGUES J P,PINHO R,RODRIGUES A,et al. Diag⁃     1056-1066
                    nostic and therapeutic yields of urgent balloon ⁃ assisted  [17] LATORRE R,LÓPEZ⁃ALBORS O,SORIA F,et al. Evi⁃
                    enteroscopy in overt obscure gastrointestinal bleeding[J].  dences supporting the vascular etiology of post ⁃ double
                    Eur J Gastroenterol Hepatol,2018,30(11):1304-1308  balloon enteroscopy pancreatitis:Study in porcine model
               [15] PINHO R,MASCARENHAS ⁃ SARAIVA M,MÃO ⁃ DE ⁃        [J]. World J Gastroenterol,2017,23(34):6201-6211
                    FERRO S,et al. Multicenter survey on the use of device⁃  [18] GIRELLI C M,POMETTA R,FACCIOTTO C,et al. First
                    assisted enteroscopy in Portugal[J]. United Eur Gastroen⁃  report of splenic rupture following deep enteroscopy[J].
                    terol J,2016,4(2):264-274                          World J Gastrointest Endosc,2016,8(9):391-394
               [16] NISHIO R,KAWASHIMA H,NAKAMURA M,et al. Dou⁃                             [收稿日期] 2021-06-29




                




               (上接第1785页)                                             [J]. Leukemia,2016,30(11):2160-2168
                    [J]. Leukemia,2017,31(10):2211-2218          [20] 蔡晓辉,陈梅玉,晁红颖,等. 骨髓增生异常综合症患者
               [14] AHN J S,KIM H J,KIM Y K,et al. Adverse prognostic ef⁃  RUNX1 基因突变分析[J]. 中国实验血液学杂志,
                    fect of homozygous TET2 mutation on the relapse risk of  2020,28(1):202-208
                    acute myeloid leukemia in patients of normal karyotype  [21] PASCHKA P,SCHLENK R F,GAIDZIK V I,et al.
                    [J]. Haematologica,2015,100(9):e351-353            ASXL1 mutations in younger adult patients with acute my⁃
               [15] ROTHENBERG ⁃ THURLEY M,AMLER S,GOERLICH            eloid leukemia:a study by the German ⁃ Austrian Acute
                    D,et al. Persistence of pre⁃leukemic clones during first re⁃  Myeloid Leukemia Study Group[J]. Haematologica,
                    mission and risk of relapse in acute myeloid leukemia[J].  2015,100(3):324-330
                    Leukemia,2018,32(7):1598-1608                [22] PRATS⁃MARTíN C,BURILLO⁃SANZ S,MORALES⁃CA⁃
               [16] AHN J S,KIM H J,KIM Y K,et al. DNMT3A R882 muta⁃   MACHO RM,et al. ASXL1 mutation as a surrogate mark⁃
                    tion with FLT3⁃ITD positivity is an extremely poor prog⁃  er in acute myeloid leukemia with myelodysplasia⁃related
                    nostic factor in patients with normal⁃karyotype acute my⁃  changes and normalkaryotype[J].Cancer Med,2020,9
                    eloid leukemia after allogeneic hematopoietic cell trans⁃  (11):3637-3646
                    plantation[J]. Biol Blood Marrow Transplant,2016,22  [23] 中华医学会血液学分会白血病淋巴瘤学组. 成人急性
                    (1):61-70                                          髓系白血病(非急性早幼粒细胞白血病)中国诊疗指南
               [17] GUO Z,ZHANG S K,ZOU Z,et al. Prognostic signifi⁃  (2017年版)[J]. 中华血液学杂志,2017,38(3):177-182
                    cance of TET2 mutations in myelodysplastic syndromes:a  [24] PAPAEMMANUIL E,CAZZOLA M,BOULTWOOD J,et
                    meta⁃analysis[J]. Leuk Res,2017,58:102-107         al. Somatic SF3B1 mutation in myelodysplasia with ring
               [18] HUNTER A M,KOMROKjI R S,YUN S,et al. Baseline      sideroblasts[J]. N Engl J Med,2011,365(15):1384-
                    and serial molecular profiling predicts outcomes with hy⁃  1395
                    pomethylating agents in myelodysplastic syndromes[J].  [25] PATNAIK M M,LASHO T L,HODNEFIELD J M,et al.
                    Blood Adv,2021,5(4):1017-1028                      SF3B1 mutations are prevalent in myelodysplastic syn⁃
               [19]GAIDZIK V I,TELEANU V,PAPAEMMANUIL E,et al.         dromes with ring sideroblasts but do not hold independent
                    RUNX1 mutations in acute myeloid leukemia are associat⁃  prognostic value[J]. Blood,2012,119(2):569-572
                    ed with distinct clinico ⁃ pathologic and genetic features              [收稿日期] 2021-03-23
   94   95   96   97   98   99   100   101   102   103   104